Show simple item record

dc.contributor.authorO'Hea, Erin L.
dc.contributor.authorCutillo, Alexandra
dc.contributor.authorDietzen, Laura
dc.contributor.authorHarralson, Tina
dc.contributor.authorGrissom, Grant
dc.contributor.authorPerson, Sharina D.
dc.contributor.authorBoudreaux, Edwin D.
dc.date2022-08-11T08:08:17.000
dc.date.accessioned2022-08-23T15:49:51Z
dc.date.available2022-08-23T15:49:51Z
dc.date.issued2013-05-01
dc.date.submitted2013-05-29
dc.identifier.citationContemp Clin Trials. 2013 May;35(1):15-24. doi: 10.1016/j.cct.2013.02.001. <a href="http://dx.doi.org/10.1016/j.cct.2013.02.001" target="_blank">Link to article on publisher's site</a>
dc.identifier.issn1551-7144 (Linking)
dc.identifier.doi10.1016/j.cct.2013.02.001
dc.identifier.pmid23395772
dc.identifier.urihttp://hdl.handle.net/20.500.14038/28531
dc.description.abstractThe National Cancer Coalition Network, National Cancer Institute, and American College of Surgeons all emphasize the need for oncology providers to identify, address, and monitor psychosocial needs of their patients. The Mental Health Assessment and Dynamic Referral for Oncology (MHADRO) is a patient-driven, computerized, psychosocial assessment that identifies, addresses, and monitors physical, psychological, and social issues faced by oncology patients. This paper presents the methodology of a randomized controlled trial (RCT) that tested the impact of the MHADRO on patient outcomes at 2, 6, and 12 months. Patient outcomes including overall psychological distress, depression, anxiety, functional disability, and use of psychosocial resources will be presented in future publications after all follow-up data is gathered. Eight hundred and thirty six cancer patients with heterogeneous diagnoses, across three comprehensive cancer centers in different parts of the United States, were randomized to the MHADRO (intervention) or an assessment-only control group. Patients in the intervention group were provided detailed, personalized reports and, when needed, referrals to mental health services; their oncology provider received detailed reports designed to foster clinical decision making. Those patients who demonstrated high levels of psychosocial problems were given the option to authorize that a copy of their report be sent electronically to a "best match" mental health professional. Demographic and patient cancer-related data as well as comparisons between patients who were enrolled and those who declined enrollment are presented. Challenges encountered during the RCT and strategies used to address them are discussed.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23395772&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/j.cct.2013.02.001
dc.subjectAdaptation, Psychological
dc.subjectMental Health
dc.subjectNeoplasms
dc.subjectPatient Satisfaction
dc.subjectReferral and Consultation
dc.subjectStress, Psychological
dc.subjectPsychological Tests
dc.subjectTherapy, Computer-Assisted
dc.subjectHealth Services Administration
dc.subjectMental and Social Health
dc.subjectOncology
dc.subjectPsychiatry
dc.subjectPsychiatry and Psychology
dc.titleRandomized control trial to test a computerized psychosocial cancer assessment and referral program: Methods and research design
dc.typeJournal Article
dc.source.journaltitleContemporary clinical trials
dc.source.volume35
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/emed_pp/74
dc.identifier.contextkey4180665
html.description.abstract<p>The National Cancer Coalition Network, National Cancer Institute, and American College of Surgeons all emphasize the need for oncology providers to identify, address, and monitor psychosocial needs of their patients. The Mental Health Assessment and Dynamic Referral for Oncology (MHADRO) is a patient-driven, computerized, psychosocial assessment that identifies, addresses, and monitors physical, psychological, and social issues faced by oncology patients.</p> <p>This paper presents the methodology of a randomized controlled trial (RCT) that tested the impact of the MHADRO on patient outcomes at 2, 6, and 12 months. Patient outcomes including overall psychological distress, depression, anxiety, functional disability, and use of psychosocial resources will be presented in future publications after all follow-up data is gathered. Eight hundred and thirty six cancer patients with heterogeneous diagnoses, across three comprehensive cancer centers in different parts of the United States, were randomized to the MHADRO (intervention) or an assessment-only control group. Patients in the intervention group were provided detailed, personalized reports and, when needed, referrals to mental health services; their oncology provider received detailed reports designed to foster clinical decision making. Those patients who demonstrated high levels of psychosocial problems were given the option to authorize that a copy of their report be sent electronically to a "best match" mental health professional. Demographic and patient cancer-related data as well as comparisons between patients who were enrolled and those who declined enrollment are presented. Challenges encountered during the RCT and strategies used to address them are discussed.</p>
dc.identifier.submissionpathemed_pp/74
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.contributor.departmentDepartment of Psychiatry
dc.contributor.departmentDepartment of Emergency Medicine
dc.source.pages15-24


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record